Biological Products

Displaying 1 - 15 of 15CSV
Villa, C. H., Biondich, P., Draper, N. L., Dores, G. M., Storch, E., Chada, K., Wong, H., Whitaker, B., Obidi, J., Vossoughi, S., Soares, A., Schilling, L. M., Natarajan, K., Goodman, M., Purkayastha, S., Zucker, R., Falconer, T., Williams, N., Reich, C., … Shoaibi, A. (2024). Patterns of platelet use evaluated in EHR networks of the Biologics Effectiveness and Safety Initiative, 2012–2018. Transfusion. Portico. https://doi.org/10.1111/trf.18114
Publication Date
Lee, K. E., Sizemore, J. A., Kim, G., Shen, B., & Sands, B. E. (2024). Impact of Biologics and Small-Molecule Agents on Postoperative Complications in IBD: A Systematic Review. Diseases of the Colon & Rectum, 67(S1), S11–S25. https://doi.org/10.1097/dcr.0000000000003222
Publication Date
Servais, L., Day, J. W., De Vivo, D. C., Kirschner, J., Mercuri, E., Muntoni, F., Proud, C. M., Shieh, P. B., Tizzano, E. F., Quijano-Roy, S., Desguerre, I., Saito, K., Faulkner, E., Benguerba, K. M., Raju, D., LaMarca, N., Sun, R., Anderson, F. A., & Finkel, R. S. (2024). Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry. Journal of Neuromuscular Diseases, 11(2), 425–442. https://doi.org/10.3233/jnd-230122
Publication Date
Ao, S., Huang, G., Tang, X., Zhu, Z., Han, J., Wang, F., & Zhai, W. (2023). Anti‐immunoglobulin E provides an additional therapy to conventional steroids for Kimura’s disease. The Journal of Dermatology, 51(4), 602–606. Portico. https://doi.org/10.1111/1346-8138.17021
Publication Date
Olén, O., Smedby, K. E., Erichsen, R., Pedersen, L., Halfvarson, J., Hallqvist-Everhov, Å., Bryder, N., Askling, J., Ekbom, A., Sachs, M. C., Sørensen, H. T., Ludvigsson, J. F., Olsson, M., Myrelid, P., Hjortswang, H., Bengtsson, J., Strid, H., Andersson, M., Jäghult, S., … Karling, P. (2023). Increasing Risk of Lymphoma Over Time in Crohn’s Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study. Clinical Gastroenterology and Hepatology, 21(12), 3132–3142. https://doi.org/10.1016/j.cgh.2023.04.001
Publication Date
Patel, R., Negassa, A., Tolu, S. S., Acuna-Villaorduna, A., & Goel, S. (2024). Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer. Clinical Colorectal Cancer, 23(1), 14-21.e1. https://doi.org/10.1016/j.clcc.2023.10.001
Publication Date
Eriksson, C., Söderling, J., Karlqvist, S., Bröms, G., Everhov, Å. H., Bergemalm, D., Ludvigsson, J. F., Olén, O., & Halfvarson, J. (2023). Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn’s Disease. Digestive Diseases and Sciences, 68(7), 3119–3128. https://doi.org/10.1007/s10620-023-07897-2
Publication Date
Smolen, J. S., Landewé, R. B. M., Bergstra, S. A., Kerschbaumer, A., Sepriano, A., Aletaha, D., Caporali, R., Edwards, C. J., Hyrich, K. L., Pope, J. E., de Souza, S., Stamm, T. A., Takeuchi, T., Verschueren, P., Winthrop, K. L., Balsa, A., Bathon, J. M., Buch, M. H., Burmester, G. R., … van der Heijde, D. (2022). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases, 82(1), 3–18. https://doi.org/10.1136/ard-2022-223356
Publication Date
Brinkley, T. E., Justice, J. N., Basu, S., Bauer, S. R., Loh, K. P., Mukli, P., Ng, T. K. S., Turney, I. C., Ferrucci, L., Cummings, S. R., & Kritchevsky, S. B. (2022). Research priorities for measuring biologic age: summary and future directions from the Research Centers Collaborative Network Workshop. GeroScience, 44(6), 2573–2583. https://doi.org/10.1007/s11357-022-00661-w
Publication Date
Lee, K. E., Faye, A. S., Vermeire, S., & Shen, B. (2022). Perioperative Management of Ulcerative Colitis: A Systematic Review. Diseases of the Colon & Rectum, 65(S1), S5–S19. https://doi.org/10.1097/dcr.0000000000002588
Publication Date
Bender, B., Oppenheimer, J., George, M., Brown, R., Patel, A., Hill, T., Boe, A., Mayen Herrera, E., Dotiwala, Z., Casciano, J., & Bernstein, J. A. (2022). Assessment of Real-World Escalation to Biologics in US Patients With Asthma. The Journal of Allergy and Clinical Immunology: In Practice, 10(11), 2941–2948. https://doi.org/10.1016/j.jaip.2022.07.016
Publication Date
Columbia Affiliation
Lawn, R. B., Murchland, A. R., Kim, Y., Chibnik, L. B., Tworoger, S. S., Rimm, E. B., Sumner, J. A., Roberts, A. L., Nishimi, K. M., Ratanatharathorn, A. D., Jha, S. C., Koenen, K. C., & Kubzansky, L. D. (2022). Trauma, psychological distress and markers of systemic inflammation among US women: A longitudinal study. Psychoneuroendocrinology, 145, 105915. https://doi.org/10.1016/j.psyneuen.2022.105915
Publication Date
Palumbo, A., Aluru, V., Battaglia, J., Geller, D., Turry, A., Ross, M., Cristian, A., Balagula, C., Ogedegbe, G., Khatri, L., Chao, M. V., Froemke, R. C., Urbanek, J. K., & Raghavan, P. (2021). Music Upper Limb Therapy–Integrated Provides a Feasible Enriched Environment and Reduces Post-stroke Depression. American Journal of Physical Medicine & Rehabilitation, 101(10), 937–946. https://doi.org/10.1097/phm.0000000000001938
Publication Date
Thunberg, J., Björkqvist, O., Hedin, C. R. H., Forss, A., Söderman, C., Bergemalm, D., Olén, O., Hjortswang, H., Strid, H., Ludvigsson, J. F., Eriksson, C., & Halfvarson, J. (2022). Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. United European Gastroenterology Journal, 10(7), 631–639. Portico. https://doi.org/10.1002/ueg2.12275
Publication Date